122 related articles for article (PubMed ID: 12950541)
1. Sleep quality among patients treated with implantable atrial defibrillation therapy: effect of nocturnal shock delivery and psychological distress.
Serber ER; Sears SF; Sotile RO; Burns JL; Schwartzman DS; Hoyt RH; Alvarez LG; Ujhelyi MR
J Cardiovasc Electrophysiol; 2003 Sep; 14(9):960-4. PubMed ID: 12950541
[TBL] [Abstract][Full Text] [Related]
2. Do patients accept implantable atrial defibrillation therapy? Results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) Study.
Burns JL; Sears SF; Sotile R; Schwartzman DS; Hoyt RH; Alvarez LG; Ujhelyi MR
J Cardiovasc Electrophysiol; 2004 Mar; 15(3):286-91. PubMed ID: 15030417
[TBL] [Abstract][Full Text] [Related]
3. Understanding atrial symptom reports: objective versus subjective predictors.
Sears SF; Serber ER; Alvarez LG; Schwartzman DS; Hoyt RH; Ujhelyi MR
Pacing Clin Electrophysiol; 2005 Aug; 28(8):801-7. PubMed ID: 16105008
[TBL] [Abstract][Full Text] [Related]
4. [Atrial defibrillator].
Jung W; Lüderitz B
Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
[TBL] [Abstract][Full Text] [Related]
5. Nitrous oxide sedation reduces discomfort caused by atrial defibrillation shocks.
Ujhelyi M; Hoyt RH; Burns K; Fishman RS; Musley S; Silverman MH
Pacing Clin Electrophysiol; 2004 Apr; 27(4):485-91. PubMed ID: 15078402
[TBL] [Abstract][Full Text] [Related]
6. Patient experiences with atrial fibrillation and treatment with implantable atrial defibrillation therapy.
Deaton C; Dunbar SB; Moloney M; Sears SF; Ujhelyi MR
Heart Lung; 2003; 32(5):291-9. PubMed ID: 14528186
[TBL] [Abstract][Full Text] [Related]
7. Determinants of first-shock success for atrial implantable cardioverter defibrillators.
Swerdlow CD; Schwartzman D; Hoyt R; Bailin SJ; Koehler JL; Warman EN;
J Cardiovasc Electrophysiol; 2002 Apr; 13(4):347-54. PubMed ID: 12033351
[TBL] [Abstract][Full Text] [Related]
8. Intracardiac atrial defibrillation.
Dosdall DJ; Ideker RE
Heart Rhythm; 2007 Mar; 4(3 Suppl):S51-6. PubMed ID: 17336885
[TBL] [Abstract][Full Text] [Related]
9. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
[TBL] [Abstract][Full Text] [Related]
10. Internal defibrillation: where we have been and where we should be going?
Lévy S
J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():61-6. PubMed ID: 16133857
[TBL] [Abstract][Full Text] [Related]
11. Self-reported sleep quality of patients with atrial fibrillation and the effects of cardioversion on sleep quality.
Kayrak M; Gul EE; Aribas A; Akilli H; Alibasiç H; Abdulhalikov T; Yildirim O; Yazici M; Ozdemir K
Pacing Clin Electrophysiol; 2013 Jul; 36(7):823-9. PubMed ID: 23437796
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial aspects of patient-activated atrial defibrillation.
Mitchell AR; Spurrell PA; Boodhoo L; Sulke N
J Cardiovasc Electrophysiol; 2003 Aug; 14(8):812-6. PubMed ID: 12890040
[TBL] [Abstract][Full Text] [Related]
13. Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life.
Newman DM; Dorian P; Paquette M; Sulke N; Gold MR; Schwartzman DS; Schaaf K; Wood K; Johnson L;
Am Heart J; 2003 May; 145(5):841-6. PubMed ID: 12766741
[TBL] [Abstract][Full Text] [Related]
14. Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system.
Lok NS; Lau CP; Tse HF; Ayers GM
J Am Coll Cardiol; 1997 Nov; 30(5):1324-30. PubMed ID: 9350935
[TBL] [Abstract][Full Text] [Related]
15. Relation of atrial refractoriness to upper and lower limits of vulnerability for atrial fibrillation/flutter following implantable ventricular defibrillator shocks.
Katz A; Sweeney RJ; Gill RM; Reid PR; Prystowsky EN
Circulation; 1999 Sep; 100(10):1125-30. PubMed ID: 10477539
[TBL] [Abstract][Full Text] [Related]
16. Predictors of sinus rhythm return during defibrillation testing in patients with permanent atrial fibrillation undergoing implantation of a cardioverter-defibrillator.
Lelakowski J; Tomala I; Cmiel A; Rydlewska A; Majewski J; Małecka B
Kardiol Pol; 2011; 69(1):17-22. PubMed ID: 21267958
[TBL] [Abstract][Full Text] [Related]
17. Specific considerations with the automatic implantable atrial defibrillator.
Jung W; Wolpert C; Esmailzadeh B; Spehl S; Herwig S; Schumacher B; Lewalter T; Omran H; Kirchhoff PG; Lüderitz B
J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S193-201. PubMed ID: 9727697
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias.
Gold MR; Sulke N; Schwartzman DS; Mehra R; Euler DE;
J Cardiovasc Electrophysiol; 2001 Nov; 12(11):1247-53. PubMed ID: 11761411
[TBL] [Abstract][Full Text] [Related]
19. Implantable Cardioverter Defibrillator Programming Characteristics, Shocked Rhythms, and Survival Among Patients Under Thirty Years of Age.
Chang PM; Powell BD; Jones PW; Carter N; Hayes DL; Saxon LA
J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1183-1190. PubMed ID: 27334356
[TBL] [Abstract][Full Text] [Related]
20. Effect of Rehabilitation on Sleep Quality After Ablation for Atrial Fibrillation: Data From a Randomized Trial.
Risom SS; Fevejle Cromhout P; Overgaard D; Hastrup Svendsen J; Kikkenborg Berg S
J Cardiovasc Nurs; 2018; 33(3):261-268. PubMed ID: 29271795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
